BCPC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Balchem Corp (BCPC) demonstrates solid financial performance and long-term growth potential, but its current valuation appears rich, and there are no strong proprietary trading signals or immediate catalysts to justify a buy decision for a beginner, long-term investor at this time. Holding is recommended until a more favorable entry point arises.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. However, the MACD histogram is negative (-0.162), suggesting weakening momentum. RSI at 65.605 is neutral, and the price is near resistance at R1: 181.968.
Record Q4 2025 earnings with 9.8% YoY revenue growth and first-ever annual sales exceeding $1 billion. Hedge funds are significantly increasing their holdings (+2062.50% last quarter).
Insider selling has surged (+1060.90% last month). Analysts find the stock's valuation 'rich' at current levels, with a Neutral rating and a price target of $162, below the current price.
In Q4 2025, revenue increased by 9.84% YoY to $263.62M, net income rose by 16.80% YoY to $39.22M, and EPS grew by 18.63% YoY to $1.21. However, gross margin slightly declined by -0.97% YoY to 35.62%.
Rothschild & Co Redburn initiated coverage with a Neutral rating and a price target of $162, citing a resilient business model but overvaluation at current levels.
